The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2023, more than 1,600, and has announced titles and authors for 30 accepted Late-breaking Abstracts (LBA). The abstracts will be presented at SITC’s upcoming 38th Annual Meeting &…